Stay updated on Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5. This indicates a minor update to the page’s revision metadata rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-08-08T18:59:45.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a minor site version update. This change reflects maintenance of the page version rather than any modification to trial content or functionality.
    Difference
    0.1%
    Check dated 2026-07-25T12:25:56.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous v3.6.2. This reflects a minor maintenance update to the page without changes to the study information or its presentation.
    Difference
    0.1%
    Check dated 2026-07-04T04:13:36.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page's revision tag is updated to v3.6.2, reflecting a new version. The previous v3.6.0 tag was removed.
    Difference
    0.1%
    Check dated 2026-06-27T02:25:14.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The page now displays the recruitment status 'No longer looking for participants' and adds new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). The 'Intervention / Treatment' label has been updated to 'Intervention/Treatment' and the revision tag updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T15:55:10.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    The revision indicator on the page updated from v3.5.4 to v3.5.5, signaling a minor update to the version history rather than a change to study content.
    Difference
    0.1%
    Check dated 2026-06-05T10:27:44.000Z thumbnail image

Stay in the know with updates to Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.